Expression of p53 Protein Is an Early Event in Ultraviolet Light-Induced Cutaneous Squamous Cell Carcinogenesis

Archives of Dermatology

Volumn 129, Issue 9, 1993, Pages 1157-1161

  Nagano, Tohru ^a   Ueda, Masato ^a   Ichihashi, Masamitsu ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ACTINIC KERATOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; XERODERMA PIGMENTOSUM;

CARCINOMA, SQUAMOUS CELL; HUMAN; MUTATION; NEOPLASMS, RADIATION-INDUCED; PROTEIN P53; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0027275779     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1993.01680300085013     Document Type: Article

References (37)

1. Bishop JM. Molecular themes in oncogenesis. Cell. 1991; 64: 235-248.
2. Ananthaswamy HN, Applegate LA, Goldberg LH, Bales ES. Deletion of the c-Ha-ras-1 allele in human skin cancers. Mol Carcinog. 1989; 2: 298-301.
3. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. ras Gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog. 1991; 4: 196-202.
4. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutation in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991; 88: 10124-10128.
5. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog. 1991; 4: 445-449.
6. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989; 57: 1083-1093.
7. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A. 1989; 86: 8763-8767.
8. Halevy O, Michalovitz D, Oren M. Different tumor-derived p53 mutants exhibit distinct biological activities. Science. 1990; 250: 113-116.
9. Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 1988; 3: 313-321.
10. Hinds P, Finlay C, Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol. 1989; 63: 739-746.
11. Bartek J, Iggo R, Gannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. 1990; 5: 893-899.
12. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989; 342: 705-708.
13. Finlay CA, Hinds PW, Tan T, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol. 1988; 8: 531-539.
14. Schwartz RA, Stoll HL Jr. Epithelial precancerous lesions. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill International Book Co; 1987: 733-746.
15. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 7th ed. Philadelphia, Pa: JB Lippincott; 1990.
16. Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991; 6: 1699-1703.
17. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci. 1992; 101: 183-189.
18. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989; 262: 2097-2100.
19. Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol. 1985; 3: 33-69.
20. Ichihashi M, Fujiwara Y. Clinical and photobiological characteristics of Japanese xeroderma pigmentosum variant. Br J Dermatol. 1981; 105: 1-12.
21. Mitchell DL, Nairn RS. The biology of the (6-4) photoproduct. Photochem Photobiol. 1989; 49: 805-819.
22. Hiramoto T, Matsunaga T, Ichihashi M, et al. Repair of 254 nm ultraviolet-induced (6-4) photoproducts: monoclonal antibody recognition and differential defects in xeroderma pigmentosum complementation groups A, D, and variant. J Invest Dermatol. 1989; 93: 703-706.
23. Slater SD, McGrath JA, Hobbs C, Eady RAJ, McKee PH. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa. Histopathology. 1992; 20: 237-241.
24. Yandell DW, Dryja TP, Little JB. Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somat Cell Mol Genet. 1986; 12: 255-263.
25. Schwartz RA, Nychay SG, Lyons M, Sciales CW, Lambert WC. Buschke-Löwenstein tumors: verrucous carcinoma of the anogenitalia. Cutis. 1991; 47: 263-266.
26. Brandsma JL, Steinberg BM, Abramson AL, Winkler B. Presence of human papilloma virus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res. 1986; 46: 2185-2188.
27. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63: 1129-1136.
28. Hubbert NL, Sedman SA, Schiller JT. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol. 1992; 66: 6237-6241.
29. Scheffner M, Münger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A. 1991; 88: 5523-5527.
30. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 1991; 6: 1785-1789.
31. Szekely L, Jiang W-Q, Bulic-Jakus F, et al. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 1992; 3: 149-156.
32. Betz NA, Pelling JC. Resistance of adult keratinocytes to differentiation-induced decrease in Ha-ras mRNA levels observed in newborn keratinocytes. Mol Carcinog. 1992; 6: 10-17.
33. Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclinB-cdc2. Proc Natl Acad Sci U S A. 1990; 87: 4766-4770.
34. Marks R, Rennie G. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988; 1: 795-797.
35. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol. 1992; 19: 302-308.
36. Baker SJ, Preisinger AC, Jessup JM, et al. p53 Gene mutations occur in combination with 17p alleic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990; 50: 7717-7722.
37. Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 1992; 52: 4828-4831.